PAUL OLDFIELD: Open Payments
NPI 1396479010 · COLORADO SPRINGS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$429 in 18 payments from 12 companies in 2025. Trend: 2023 $301 · 2024 $258 · 2025 $429
Food & beverage: $429
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 4 | $76 |
| Inspire Medical Systems, Inc. | 1 | $57 |
| Aimmune Therapeutics, Inc. | 2 | $43 |
| Novo Nordisk Inc | 2 | $41 |
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
| Alexion Pharmaceuticals, Inc. | 1 | $31 |
| Otsuka America Pharmaceutical, Inc. | 1 | $30 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $29 |
| ANI Pharmaceuticals, Inc. | 1 | $25 |
| Ossur Americas, Inc. | 1 | $24 |
Products named: KRYSTEXXA, INSPIRE, ZENPEP, ULTOMIRIS, JYNARQUE, JARDIANCE, PURIFIED CORTROPHIN GEL, Ozempic.
Industry payments across CO — which companies pay providers there.
